Loading…
Genomic Research and Accessibility Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
64pct
20d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (8)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2011 · second_quarter · Food Industry (safety, labeling, etc.)
The Genomic Research and Accessibility Act (no bill # this session, previously H.R 977 in 2007) Gene Patenting S. 299: A bill to amend the Federal Food, Drug, and Cosmetic Act to Require the Labeling of Genetically-Engineered Fish -S. 230: A bill to amend the Federal Food, Drug, and Cosmetic Act to Prevent the Approval of Genetically-Engineered Fish -H.R. 520: A bill to amend the Federal Food, Drug, and Cosmetic Act to Require the Labeling of Genetically-Engineered Fish -H.R. 521: S. 230: A bill to amend the Federal Food, Drug, and Cosmetic Act to Prevent the Approval of Genetically-Engineered Fish -Docket No. FDA-2010-N-0385; Labeling of AquAdvantage genetically engineered salmon -Docket No. FDA2010N0001; FDA meeting on the Approval of AquaAdvantage genetically engineered salmon -Comments on NOAAs Aquaculture Feeds Alternative Report -Comments on DOE NEPA Implementing Procedures, RIN 1990-AA34
Client expense: $18,688 · Firm income: Not reported
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2011 · first_quarter · Food Industry (safety, labeling, etc.)
The Genomic Research and Accessibility Act (no bill # this session, previously H.R 977 in 2007) Gene Patenting S. 299: A bill to amend the Federal Food, Drug, and Cosmetic Act to Require the Labeling of Genetically-Engineered Fish -S. 230: A bill to amend the Federal Food, Drug, and Cosmetic Act to Prevent the Approval of Genetically-Engineered Fish -H.R. 520: A bill to amend the Federal Food, Drug, and Cosmetic Act to Require the Labeling of Genetically-Engineered Fish -H.R. 521: S. 230: A bill to amend the Federal Food, Drug, and Cosmetic Act to Prevent the Approval of Genetically-Engineered Fish -Docket No. FDA-2010-N-0385; Labeling of AquAdvantage genetically engineered salmon -Docket No. FDA2010N0001; FDA meeting on the Approval of AquaAdvantage genetically engineered salmon -Comments on NOAAs Aquaculture Feeds Alternative Report -Comments on DOE NEPA Implementing Procedures, RIN 1990-AA34
Client expense: $14,626 · Firm income: Not reported
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Banking
Public Law 110-234, regarding the regulatory implementation of the provisions regulating the off exchange trading of foreign exchange. Public Law 110-246, regarding implementation of the provisions relating to foreign exchange. HR 4173 "Wall Street Reform and Consumer Protection Act of 2009," all provisions relating to foreign exchange. HR 3795 "Over-the-Counter Derivatives Markets Act of 2009," all provisions relating to foreign exchange. HR 977 "Derivatives Markets Transparency and Accountability Act of 2009, " all provisions relating to foreign exchange. S 1691 "Comprehensive Derivatives Regulation Act of 2009," all provisions relating to foreign exchange. "Restoring American Financial Stability Act of 2010," as reported by the Senate Banking Committee (to become S 3217), all provisions pertaining to Title VIIImprovements to Regulation of Over-the-Counter Derivatives Markets. CFTC Proposed Rule pertaining to the Regulation of Off-Exchange Retail Foreign Exchange Transactions and Intermediaries, all provisions in Part 5, Section 5.9, pages 139-40. PL 111-203 Dodd-Frank Wall Street Reform and Consumer Protection Act, regarding implementation of the provisions relating to the determination by the Department of the Treasury as to whether foreign currency swaps and forwards are covered by the relevant provisions of Title VII. CFTC Final Rule 75 FR 55409 Regulation of Off-Exchange Retail Foreign Exchange Transactions and Intermediaries, regarding implementation of the provisions in 17 CFR Part 5 relating to retail foreign exchange dealers and leverage requirements.
Client expense: Not reported · Firm income: $50,000
Government targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Banking
Public Law 110-234, regarding the regulatory implementation of the provisions regulating the off exchange trading of foreign exchange. Public Law 110-246, regarding implementation of the provisions relating to foreign exchange. HR 4173 "Wall Street Reform and Consumer Protection Act of 2009," all provisions relating to foreign exchange. HR 3795 "Over-the-Counter Derivatives Markets Act of 2009," all provisions relating to foreign exchange. HR 977 "Derivatives Markets Transparency and Accountability Act of 2009, " all provisions relating to foreign exchange. S 1691 "Comprehensive Derivatives Regulation Act of 2009," all provisions relating to foreign exchange. "Restoring American Financial Stability Act of 2010," as reported by the Senate Banking Committee (to become S 3217), all provisions pertaining to Title VIIImprovements to Regulation of Over-the-Counter Derivatives Markets. CFTC Proposed Rule pertaining to the Regulation of Off-Exchange Retail Foreign Exchange Transactions and Intermediaries, all provisions in Part 5, Section 5.9, pages 139-40. PL 111-203 Dodd-Frank Wall Street Reform and Consumer Protection Act, regarding implementation of the provisions relating to the determination by the Department of the Treasury as to whether foreign currency swaps and forwards are covered by the relevant provisions of Title VII. CFTC Final Rule 75 FR 55409 Regulation of Off-Exchange Retail Foreign Exchange Transactions and Intermediaries, regarding implementation of the provisions in 17 CFR Part 5 relating to retail foreign exchange dealers and leverage requirements.
Client expense: Not reported · Firm income: $50,000
Government targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Banking
Public Law 110-234, regarding the regulatory implementation of the provisions regulating the off exchange trading of foreign exchange. Public Law 110-246, regarding implementation of the provisions relating to foreign exchange. HR 4173 "Wall Street Reform and Consumer Protection Act of 2009," all provisions relating to foreign exchange. HR 3795 "Over-the-Counter Derivatives Markets Act of 2009," all provisions relating to foreign exchange. HR 977 "Derivatives Markets Transparency and Accountability Act of 2009, " all provisions relating to foreign exchange. S 1691 "Comprehensive Derivatives Regulation Act of 2009," all provisions relating to foreign exchange. "Restoring American Financial Stability Act of 2010," as reported by the Senate Banking Committee (to become S 3217), all provisions pertaining to Title VIIImprovements to Regulation of Over-the-Counter Derivatives Markets. CFTC Proposed Rule pertaining to the Regulation of Off-Exchange Retail Foreign Exchange Transactions and Intermediaries, all provisions in Part 5, Section 5.9, pages 139-40.
Client expense: Not reported · Firm income: $50,000
Government targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Banking
Public Law 110-234, regarding the regulatory implementation of the provisions regulating the off exchange trading of foreign exchange. Public Law 110-246, regarding implementation of the provisions relating to foreign exchange. HR 4173 "Wall Street Reform and Consumer Protection Act of 2009," all provisions relating to foreign exchange. HR 3795 "Over-the-Counter Derivatives Markets Act of 2009," all provisions relating to foreign exchange. HR 977 "Derivatives Markets Transparency and Accountability Act of 2009, " all provisions relating to foreign exchange. S 1691 "Comprehensive Derivatives Regulation Act of 2009," all provisions relating to foreign exchange. "Restoring American Financial Stability Act of 2010," as reported by the Senate Banking Committee (to become S 3217), all provisions pertaining to Title VIIImprovements to Regulation of Over-the-Counter Derivatives Markets. CFTC Proposed Rule pertaining to the Regulation of Off-Exchange Retail Foreign Exchange Transactions and Intermediaries, all provisions in Part 5, Section 5.9, pages 139-40.
Client expense: Not reported · Firm income: $50,000
Government targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Banking
Public Law 110-234, regarding the regulatory implementation of the provisions regulating the off exchange trading of foreign exchange. Public Law 110-246, regarding implementation of the provisions relating to foreign exchange. HR 4173 "Wall Street Reform and Consumer Protection Act of 2009," all provisions relating to foreign exchange. HR 3795 "Over-the-Counter Derivatives Markets Act of 2009," all provisions relating to foreign exchange. HR 977 "Derivatives Markets Transparency and Accountability Act of 2009, " all provisions relating to foreign exchange. S 1691 "Comprehensive Derivatives Regulation Act of 2009," all provisions relating to foreign exchange.
Client expense: Not reported · Firm income: $50,000
Government targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Banking
Public Law 110-234, regarding the regulatory implementation of the provisions regulating the off exchange trading of foreign exchange. Public Law 110-246, regarding implementation of the provisions pertaining to foreign exchange. S 272 "Derivatives Trading Integrity Act of 2009," all provisions pertaining to foreign exchange. HR 977 "Derivatives Markets Transparency and Accountability Act of 2009, " all provisions pertaining to foreign exchange. HR 2454 "American Clean Energy and Security Act of 2009," all provisions pertaining to foreign exchange. S 447 "Prevent Excessive Speculation Act," all provisions pertaining to foreign exchange. S 1691 "Comprehensive Derivatives Regulation Act of 2009," all provisions pertaining to foreign exchange.
Client expense: Not reported · Firm income: $50,000
Government targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Banking
S 272 "Derivatives Trading Integrity Act of 2009," all provisions pertaining to foreign exchange. HR 977 "Derivatives Markets Transparency and Accountability Act of 2009, " all provisions pertaining to foreign exchange. Public Law 110-234, regarding the regulatory implementation of the provisions regulating the off exchange trading of foreign exchange. Public Law 110-246, regarding implementation of the provisions pertaining to foreign exchange.
Client expense: Not reported · Firm income: $50,000
Government targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Financial Institutions/Investments/Securities
BAN: HR627, S414, HR1214, S500, S582, HR1456, HR3126; ECN: HR1664, HR1586, SB812, HR1, TARP II: HR384; Bankruptcy Reform: HR1106, HR200, HR225, SB257; Budget Resolutions: S. Con. Res. 13, H. Con. Res. 85; Mortgage: HR1728, HR788, HR1782; Derivatives: HR977
Client expense: Not reported · Firm income: Not reported
2008 · second_quarter · Bankruptcy
BAN: HR627, S414, HR1214, S500, S582, HR1456, HR3126; ECN: HR1664, HR1586, SB812, HR1, TARP II: HR384; Bankruptcy Reform: HR1106, HR200, HR225, SB257; Budget Resolutions: S. Con. Res. 13, H. Con. Res. 85; Mortgage: HR1728, HR788, HR1782; Derivatives: HR977
Client expense: Not reported · Firm income: Not reported
2008 · second_quarter · Economics/Economic Development
BAN: HR627, S414, HR1214, S500, S582, HR1456, HR3126; ECN: HR1664, HR1586, SB812, HR1, TARP II: HR384; Bankruptcy Reform: HR1106, HR200, HR225, SB257; Budget Resolutions: S. Con. Res. 13, H. Con. Res. 85; Mortgage: HR1728, HR788, HR1782; Derivatives: HR977
Client expense: Not reported · Firm income: Not reported
2008 · second_quarter · Banking
BAN: HR627, S414, HR1214, S500, S582, HR1456, HR3126; ECN: HR1664, HR1586, SB812, HR1, TARP II: HR384; Bankruptcy Reform: HR1106, HR200, HR225, SB257; Budget Resolutions: S. Con. Res. 13, H. Con. Res. 85; Mortgage: HR1728, HR788, HR1782; Derivatives: HR977
Client expense: Not reported · Firm income: Not reported
2008 · second_quarter · Housing
BAN: HR627, S414, HR1214, S500, S582, HR1456, HR3126; ECN: HR1664, HR1586, SB812, HR1, TARP II: HR384; Bankruptcy Reform: HR1106, HR200, HR225, SB257; Budget Resolutions: S. Con. Res. 13, H. Con. Res. 85; Mortgage: HR1728, HR788, HR1782; Derivatives: HR977
Client expense: Not reported · Firm income: Not reported
2008 · second_quarter · Budget/Appropriations
BAN: HR627, S414, HR1214, S500, S582, HR1456, HR3126; ECN: HR1664, HR1586, SB812, HR1, TARP II: HR384; Bankruptcy Reform: HR1106, HR200, HR225, SB257; Budget Resolutions: S. Con. Res. 13, H. Con. Res. 85; Mortgage: HR1728, HR788, HR1782; Derivatives: HR977
Client expense: Not reported · Firm income: Not reported
2008 · second_quarter · Science/Technology
s 2258, hr 5910, hr 977, hr 5940, biotechnology
Client expense: $31,738 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 1237 / S. 2510: The Cytology Proficiency Improvement Act of 2007 - Cytology Proficiency Testing - Support legislation that would modernize and improve an outdated federal proficiency test required by pathologists who examine Pap test to screen for cervical cancer. S. 976: Genomics and Personalized Medicine Act of 2007 - Regulation of Genetic Testing - The CAP supports continued regulation of genetic testing through existing CLIA law. S. 736: The Laboratory Test Improvement Act - Regulation of Genetic Testing - The CAP supports continued regulation of genetic testing through existing CLIA law. H.R. 977: The Genomic Research and Accessibility Act - Gene Patents - Support legislation that prohibits gene patents or exempts lab based personnel from patent violations when performing laboratory developed tests.
Client expense: $193,188 · Firm income: Not reported
2008 · fourth_quarter · Health Issues
S 898/HR 1560 - Alzheimer's Breakthrough Act of 2007 S 558/HR 1424 - Mental Health Parity Act of 2007 S 325/HR 506 - Health Partnership Act H.R.6282/S 2950 - Helping HANDS for Autism Act of 2008 H.R. 1669/S 982 - Positive Aging Act of 2007 H.R. 1424 - Emergency Economic Stabilization Act of 2008 H.R. 3 - Stem Cell Research Enhancement Act of 2007 H.R. 1621/ S 799- Community Choice Act of 2007 S. 2267- Americans Giving Care to Elders Act of 2007 S. 1758/HR 3001- Community Living Assistance Services and Supports Act H.R. 4897/S. 1854- Stop Senior Suicide Act H.R. 977 - The Genomic Research and Accessibility Act Long-Term Care Social Service Block Grant S 937/HR 1881 - Expanding the Promise for Individuals With Autism Act of 2007 HR 7202- Temporary Tax Relief Act of 2008 HR 6049- Renewable Energy and Job Creation Act of 2008
Client expense: $34,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), SENATE, State, Dept of (DOS), White House Office
2008 · third_quarter · Medical/Disease Research/Clinical Labs
Cytology Proficiency Testing- Support legislation that would modernize and improve an outdated federal proficiency test required by pathologists who examine Pap test to screen for cervical cancer. (H.R. 1237 and S 2510 both named The Cytology Proficiency Improvement Act of 2007); Regulation of Genetic Testing- The CAP supports continued regulation of genetic testing through existing CLIA law (S. 976, Genomics and Personalized Medicine Act of 2007 and S. 736 the Laboratory Test Improvement Act); Genetic Discrimination- Support legislation banning employers from discrimination based on genetic information. (H.R. 483 and S. 358, both titled the Genetic Information Non Discrimination Act of 2007 and signed into law in spring 2008) Gene Patents- Support legislation that prohibits gene patents or exempts lab based personnel from patent violations when performing laboratory developed tests. (H.R. 977, the Genomic Research and Accessibility Act)
Client expense: $323,257 · Firm income: Not reported
2008 · third_quarter · Health Issues
S 898/HR 1560 - Alzheimer's Breakthrough Act of 2007 S 558 - Mental Health Parity Act of 2007 S 325/HR 506 - Health Partnership Act H.R.6282/S 2950 - Helping HANDS for Autism Act of 2008 H.R. 1669/S 982 - Positive Aging Act of 2007 H.R. 1424 - Emergency Economic Stabilization Act of 2008 H.R. 3 - Stem Cell Research Enhancement Act of 2007 H.R. 1621/ S 799- Community Choice Act of 2007 S. 2267- Americans Giving Care to Elders Act of 2007 S. 1758/HR 3001- Community Living Assistance Services and Supports Act H.R. 4897- Stop Senior Suicide Act H.R. 977 - The Genomic Research and Accessibility Act Long-Term Care Social Service Block Grant S 1758/HR 30001 - CLASS Act S 937/HR 1881 - Expanding the Promise for Individuals With Autism Act of 2007 HR 6983 - To amend section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans, and for other purposes. HR 7202- Temporary Tax Relief Act of 2008 HR 6049- Renewable Energy and Job Creation Act of 2008
Client expense: $51,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), SENATE, State, Dept of (DOS), White House Office
2008 · second_quarter · Science/Technology
S. 2358, HR 5910, HR 977, HR 5940, Biotechnology
Client expense: Not reported · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Science/Technology
S. 2358, HR 5910, HR 977, HR 5940, Biotechnology
Client expense: Not reported · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
S 898/HR 1560 - Alzheimer's Breakthrough Act of 2007 S 558 - Mental Health Parity Act of 2007 S 325/HR 506 - Health Partnership Act H.R.6282/S 2950 - Helping HANDS for Autism Act of 2008 H.R. 1669/S 982 - Positive Aging Act of 2007 H.R. 1424 - Paul Wellstone Mental Health and Addiction Equity Act of 2007 H.R. 3 - Stem Cell Research Enhancement Act of 2007 H.R. 1621/ S 799- Community Choice Act of 2007 S. 2267- Americans Giving Care to Elders Act of 2007 S. 1758/HR 3001- Community Living Assistance Services and Supports Act H.R. 4897- Stop Senior Suicide Act S. 358/HR 493 - Genetic Information Nondiscrimination Act of 2007 H.R. 977 - The Genomic Research and Accessibility Act Long-Term Care Social Service Block Grant S 1758/HR 30001 - CLASS Act S 937/HR 1881 - Expanding the Promise for Individuals With Autism Act of 2007
Client expense: $68,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), SENATE, State, Dept of (DOS), White House Office
2008 · first_quarter · Science/Technology
Issues regarding intellectual property and furthering research. Specific legislation: HR 977, Genomic Research and Accessibility Act (the entire bill).
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Combating Autism Act and Expanding the Promise for Individuals with Autism Act S. 898 - Alzheimer's Breakthrough Act of 2007 S. 558- Mental Health Parity Act of 2007 S. 325 - Health Partnership Act H.R. 1688 - All Healthy Children Act of 2007 H.R. 1669 - Positive Aging Act of 2007 H.R. 1560 - Alzheimer's Breakthrough Act of 2007 H.R. 1424 - Paul Wellstone Mental Health and Addiction Equity Act of 2007 H.R. 506 - Health Partnership Act H.R. 3 - Stem Cell Research Enhancement Act of 2007 H.R. 1621- Community Choice Act of 2007 S. 799- Community Choice Act of 2007 H.R. 3533- Public and Teaching Hospital Preservation Act S. 1893 Children's Health Insurance Program Reauthorization Act of 2007 S. 2267- Americans Giving care to Elders Act of 2007 S. 1758- Community Living Assistance Services and Supports Act H.R. 4897- Stop Senior Suicide Act H.R. 3001 Community Living Assitance Services and Supports Act Social Security Block Grants S. 358 - Genetic Information Nondiscrimination Act of 2007 H.R. 977 - The Genomic Research and Accessibility Act H.R. 493 - Genetic Information Nondiscrimination Act of 2007 S. 982 - Positive Aging Act of 2007 Long-Term Care Medicaid Medicare Long-Term Care Reform Mental Health parity Older Americans Act Title IV Social Security Block Grants Mental Health Approps Autism Community Living Assistance Services and Supports Act Health Partnership Act
Client expense: $66,771 · Firm income: Not reported
2008 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 977- Genomic Research and Accessibility Act; S. 976- Genomics and Personalized Medicine Act of 2007; S. 736- Laboratory Test Improvement Act- MED; S. 624- National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007; H.R. 1132 - National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 (Received in Senate from House); H.R. 2626- Comprehensive HealthCARE (Coverage and Reform Enhancement) Act; H.R. 493- Genetic Information Nondiscrimination Act of 2007; S.358- Genetic Information Nondiscrimination Act of 2007
Client expense: $237,777 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Medical/Disease Research/Clinical Labs
Cytology Proficiency Testing- Support legislation that would modernize and improve an outdated federal proficiency test required by pathologists who examine Pap test to screen for cervical cancer. (H.R. 1237 and S 2510 both named The Cytology Proficiency Improvement Act of 2007); Regulation of Genetic Testing- The CAP supports continued regulation of genetic testing through existing CLIA law (S. 976, Genomics and Personalized Medicine Act of 2007 and S. 736 the Laboratory Test Improvement Act); Genetic Discrimination- Support legislation banning employers from discrimination based on genetic information. (H.R. 483 and S. 358, both titled the Genetic Information Non Discrimination Act of 2007 and signed into law in spring 2008) Gene Patents- Support legislation that prohibits gene patents or exempts lab based personnel from patent violations when performing laboratory developed tests. (H.R. 977, the Genomic Research and Accessibility Act)
Client expense: $239,500 · Firm income: Not reported
2007 · mid_year · Science/Technology
HR 977 Genomic Research, EPA-HQ-OPP-2006-0175 Pesticides and Food Packaging
Client expense: $22,764 · Firm income: Not reported
2007 · year_end · Copyright/Patent/Trademark
Patent Reform H.R. 1908 S. 1145 Gene Patenting H.R. 977 ITC Exclusion Orders - Impact on Biotechnology Qualcomm Case CBD TRIPS Amendment Patent Disclosure Requirements PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71-FR-38808 Alternative Claims Rule: 72-FR-154 Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Bayh-Dole Act Evaluation International Intellectual Property Enforcement Anti-counterfeiting IP Provisions in Free Trade Agreements
Client expense: $3,560,000 · Firm income: Not reported
2007 · year_end · Medical/Disease Research/Clinical Labs
H.R. 977-Genomic Research and Accessibility Act; S. 976-Genomics and Personalized Medicine Act of 2007; S. 736-Laboratory Test Improvement Act- MED; H.R. 2626-Comprehensive HealthCARE (Coverage and Reform Enhancement) Act; H.R. 493-Genetic Information Nondiscrimination Act of 2007; S.358-Genetic Information Nondiscrimination Act of 2007; H.R. 3453-Community Clinical Laboratory Fairness in Competition Act of 2007; S. 2099-Preserving Access to Laboratory Services of 2007;
Client expense: $439,684 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Copyright/Patent/Trademark
H.R. 1908, S. 1145 Patent Reform legislation -- against inclusion of a research use exemption provision in patent reform legislation. Concerns regarding post grant opposition and apportionment of damages provisions. HR 977 - re Gene Patents, Against; against inclusion of a research use exemption
Client expense: $320,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Science/Technology
Issues regarding intellectual property and furthering research. Specific legislation: HR 977, Genomic Research and Accessibility Act (the entire bill).
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Health Issues
S. 358 - Genetic Information Nondiscrimination Act of 2007 H.R. 977 - The Genomic Research and Accessibility Act H.R. 493 - Genetic Information Nondiscrimination Act of 2007 S. 982 - Positive Aging Act of 2007
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
2007 · mid_year · Science/Technology
HR 977 Genomic Research and Accessibility Act EPA-HQ-OPP-2006-0175 Pesticides; Food Packaging Treated with a Pesticide (Nanotechnology)
Client expense: $22,764 · Firm income: Not reported
2007 · mid_year · Medical/Disease Research/Clinical Labs
H.R. 493- Genetic Information Nondiscrimination Act of 2007; S.358- Genetic Information Nondiscrimination Act of 2007 H.R. 977- Genomic Research and Accessibility Act; S. 976- Genomics and Personalized Medicine Act of 2007; S. 736- Laboratory Test Improvement Act- MED; S. 624- National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007; H.R. 1132 - National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 (Received in Senate from House); H.R. 2626- Comprehensive HealthCARE (Coverage and Reform Enhancement) Act;
Client expense: $564,670 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Copyright/Patent/Trademark
Patent Reform H.R. 1908: Patent Reform Act of 2007 S. 1145: Patent Reform Act of 2007 Bayh-Dole Act PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71 FR 38808 CBD TRIPS Amendment Genetic Origin Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Intellectual Property Protections as Part of Panama and Peru Free Trade Agreements International Intellectual Property Enforcement Bill ITC Exclusion Orders - Impact on Biotechnology ITC Remedy Qualcomm Case Substantive Patent Law Harmonization U.S. Government Negotiation Positions Gene Patenting H.R. 977: A bill to prohibit gene patents
Client expense: $3,600,000 · Firm income: Not reported
2007 · mid_year · Science/Technology
Issues regarding intellectual property and furthering research. Specific legislation: HR 977, Genomic Research and Accessibility Act (the entire bill).
Client expense: $320,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Health Issues
S. 898 - Alzheimer's Breakthrough Act of 2007 S. 558 - Mental Health Parity Act of 2007 S. 325 - Health Partnership Act S. 5 - Stem Cell Research Enhancement Act of 2007 H.R. 1688 - All Healthy Children Act of 2007 H.R. 1669 - Positive Aging Act of 2007 H.R. 1560 - Alzheimer's Breakthrough Act of 2007- H.R. 1424 - Paul Wellstone Mental Health and Addiction Equity Act of 2007 H.R. 506 - Health Partnership Act H.R. 3 - Stem Cell Research Enhancement Act of 2007 S. 358 - Genetic Information Nondiscrimination Act of 2007 H.R. 977 - The Genomic Research and Accessibility Act H.R. 493 - Genetic Information Nondiscrimination Act of 2007 S. 982 - Positive Aging Act of 2007
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
| Democratic |
| CA |
| Julia Carson | Democratic | IN |
| Linda T. Sánchez | Democratic | CA |
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Park Service (NPS), SENATE, UNDETERMINED
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), UNDETERMINED, White House Office
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Park Service (NPS), SENATE
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office